Prevalence of Rheumatic Diseases and Quality of Life in the Saraguro Indigenous People, Ecuador: A Cross-sectional Community-Based Study.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
16
8
2019
medline:
24
6
2021
entrez:
16
8
2019
Statut:
ppublish
Résumé
Rheumatic diseases are more prevalent and aggressive in indigenous population groups, providing medical attention for which poses a challenge for the rheumatologist. To estimate the prevalence of musculoskeletal (MSK) disorders and rheumatic diseases in the Saraguro indigenous people in Ecuador, as well as to identify the main factors associated with the health status of this population. This observational, cross-sectional study focused on the community was conducted using the COPCORD (Community-Oriented Program for Control of Rheumatic Diseases) methodology. The required data were obtained using the following instruments: (1) a screening for MSK disorders and rheumatic diseases; (2) a sociodemographic questionnaire; (3) a functional capacity Health Assessment Questionnaire Disability Index questionnaire; and (4) the quality of life EQ-5D-3L (EuroQoL) questionnaire. The rheumatologists working with the indigenous community were responsible for examining and treating study participants suffering from MSK disorders. The study sample comprised 2687 individuals, with mean age of 44 (SD, 19.9) years, 1690 (62.9%) of whom were women; Kichwa speakers comprised 32.4% (872), and 1244 (46.3%) reported MSK pain. The most prevalent conditions were as follows: low back pain (9.3%), hand osteoarthritis (OA, 7.2%), knee OA (6.5%), rheumatic regional pain syndrome (5.8%), fibromyalgia (1.8%), and rheumatoid arthritis (1.3%). Lower education level, unemployment, cooking with firewood, and rheumatic diseases were associated with a lower quality of life. Musculoskeletal disorders, rheumatic diseases, and rheumatoid arthritis were found to be highly prevalent in the studied population. Rheumatoid arthritis and hand OA had the most significant impact on the quality of life.
Identifiants
pubmed: 31415477
doi: 10.1097/RHU.0000000000001131
pii: 00124743-202010002-00009
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
S139-S147Références
Cardiel MH. Present and future of rheumatic diseases in Latin America. Are we prepared to face them?Rheumatol Clin. 2011;7:279–280.
Loyola-Sanchez A, Richardson J, Peláez-Ballestas I, et al. The impact of arthritis on the physical function of a rural Maya-Yucateco community and factors associated with its prevalence: a cross-sectional, community-based study. Clin Rheumatol. 2016;35:25–34.
Montenegro RA, Stephens C. Indigenous health in Latin America and the Caribbean. Lancet. 2006;367:1859–1869.
Loyola-Sanchez A, Hurd K, Barnabe C, et al. Healthcare utilization for arthritis by indigenous populations of Australia, Canada, New Zealand, and the United States: a systematic review. Semin Arthritis Rheum. 2017;46:665–674.
Peláez-Ballestas I, Alvarez-Nemegyei J, Loyola-Sánchez A, et al. Prevalence and factors associated with musculoskeletal disorders and rheumatic diseases in indigenous Maya-Yucateco people: a cross-sectional community-based study. Clin Rheumatol. 2016;35:15–23.
Quintana R, Silvestre A, Goñi M, et al. Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina. Clin Rheumatol. 2016;35:5–14.
Pons-Estel B, Catoggio L, Cardiel M, et al. The GLADEL multinational Latin American prospective inception cohort of 1.214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore). 2004;83:1–17.
Secretaría Nacional de Planificación y Desarrollo—Senplades. Plan Nacional de Desarrollo / Plan Nacional para el Buen Vivir 2013–2017 [website]. 2013. Available at: www.observatorioplanificacion.cepal.org. Accessed April 3, 2019.
Valeggia CR, Snodgrass JJ. Health of indigenous peoples. Ann Rev Anthropol. 2015;44:117–135.
Wigley R, Manahan L, Muirden KD, et al. Rheumatic disease in a Philippine village II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int. 1991;11:157–161.
Sarango F. Los Saraguros. In: Almeida Vinneza J, ed. Identidades Indias del Ecuador Contemporáneo. Cayambe, Ecuador: Abya-Yala; 1995:339–363.
Syring D. With the Saraguros: The Blended Life in a Transnational World. Austin, TX: University of Texas Press; 2014.
Armijos C, Cota I, González S. Traditional medicine applied by the Saraguro yachakkuna: a preliminary approach to the use of sacred and psychoactive plant species in the southern region of Ecuador. J Ethnobiol Ethnomed. 2014;10:26.
Schmitz W. Interethnic relations in Saraguro (Ecuador) from the anthropology of communication. Man Life J Inst Soc Res Appl Anthropol (Calcutta). 1983;9:35–52.
Lucio R, Villacrés N, Henríquez R. Sistema de Salud de Ecuador. Salud Pública Méx [serial online]. 2011;53:s177–s187. Available at: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000800013&lng=es. Accessed April 3, 2019.
Cardiel MH, Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol. 2002;20:617–624.
Instituto Nacional de Estadísticas y Censos del Ecuador, INEC (2010). Available at: http://www.inec.gob.ec/tabulados. Accessed March 8, 2018.
Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011;86:3–8.
Guevara-Pacheco S, Feicán-Alvarado A, Peláez-Ballestas I, et al. Estudio Descriptivo: Detección del dolor músculo—esquelétrico y Enfermedades Reumáticas aplicando el COPCORD en la población indígena de Saraguro—Ecuador. Rev Méd Hosp José Carrasco Arteaga. 2018;10:126–132.
Moreno-Montoya J, Alvarez-Nemegyei J, Trejo-Valdivia B. Assessment of the dimensions, construct validity, and utility for rheumatoid arthritis screening of the COPCORD instrument. Clin Rheumatol. 2014;33:631–636.
The EuroQoL Group. EuroQoL a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33:1601–1610.
Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the Knee. Diagnostic and Therapeutic Criteria of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–1049.
Wolfe F, Smythe H, Yunnus M, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicentric Criteria Committee. Arthritis Rheum. 1990;33:160–172.
Wallace S, Robinson H, Masi A, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895–900.
Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back in pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann Rheum Dis. 2009;68:784–788.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for applications as classification and diagnostic criteria. Arthritis Rheum. 2006;54:569–578.
Alvarez J, Peláez-Ballestas I, Rodriguez-Amado J, et al. Prevalence of rheumatic regional pain syndromes in adults from Mexico: a community survey using COPCORD for screening and syndrome-specific diagnostic criteria. J Rheumatol. 2011;38:15–20.
Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all the odds. Soc Sci Med. 1999;48:977–988.
Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004;63:723–729.
Ferreira P, Goncalves S, Ferreira L, et al. Assessing the quality of life of self-reported rheumatic patients. Rheumatol Int. 2016;36:1265–1274.
Esquivel-Valerio JA, Orzua-de la Fuente WM, Vázquez-Fuentes BR, et al. The impact of osteoarthritis on the functioning and health status of a low-income population: an example of a disability paradox. J Clin Rheumatol. 2018;24:57–64.
Obregón-Ponce A, Iraheta I, García-Ferrer H, et al. A prevalence of musculoskeletal diseases in Guatemala, Central America. The COPCORD study of 2 populations. J Clin Rheumatol. 2012;18:170–174.
Peláez-Ballestas I, Granados Y, Quintana R, et al. Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem. Ann Rheum Dis. 2018;77:1397–1404.
Briggs A, Woolf A, Dreinhöfer K, et al. Reducing the global burden of musculoskeletal conditions. Bull World Health Organ. 2018;96:366–368.
Del Rio Nájera D, Santana N, Peláez-Ballestas I, et al. Prevalence of rheumatic diseases in Raramuri people in Chihuahua, México: a community-based study. Clin Rheumatol. 2016;35:43–52.
Granados Y, Rosillo C, Cedeño L, et al. Prevalence of musculoskeletal disorders and rheumatic disease in the Warao, Kariña, and Chaima indigenous populations of Monagas State, Venezuela. Clin Rheumatol. 2016;35:53–61.
Julian-Santiago F, García-García C, García-Olivera I, et al. Epidemiology of rheumatic diseases in Mixtec and Chontal indigenous communities in Mexico: a cross-sectional community-based study. Clin Rheumatol. 2016;35:35–42.
Esen S, Esen İ, Karabulut Y, et al. Effects of the disease characteristics and the treatment on psychological status in patients with rheumatoid arthritis and ankylosing spondylitis. Curr Rheumatol Rev. 2018;14:271–278.
Mcdougal C, Hurd K, Barnabe C. Systematic review rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum. 2017;46:675–686.
Rydell E, Forslind K, Kenilsson J, et al. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis. Arthritis Res Ther. 2018;20:82.
Uhunmwangho C, Dungwom S, Imoh L, et al. Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology. Clin Rheumatol. 2017;36:2509–2516.
Guevara S, Feicán A, Peláez-Ballestas I, et al. Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador. A WHO-COPCORD study. Rheumatol Int. 2016;36:1195–2014.
Senna ER, De Barros AL, Silva EO, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31:594–597.
Vincent A, Lahr B, Wolfe F, et al. Prevalence of fibromyalgia: population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res. 2013;65:786–792.
Gelonch O, Garolera M, Valls J, et al. The effect of depressive symptoms oncognitionn in patients with fibromyalgia. PLoS One. 2018;13:1–20.
De Heer E, Vriezkolk J, van der Feltz-Cornelis C. Poor illness perceptions and anxious symptomatology in fibromyalgia syndrome: a longitudinal cohort study. Front Psych. 2017;8:1–8.
Revuelta E, Segura E, Tevar P. Depresión, ansiedad y fibromialgia. Rev Soc Esp Dolor. 2010;17:326–332.
Chang M, Hsu J, Huang K, et al. Bidirectional association between depression and fibromyalgia syndrome: a nationwide longitudinal study. J Pain. 2015;16:895–902.
Sancassiani F, Machado S, Ruggiero V, et al. The management of fibromyalgia from a psychosomatic perspective: an overview. Int Rev Psychiatry. 2017;29:473–488.
Guevara-Pacheco SV, Feican-Alvarado A, Delgado-Pauta J, et al. Prevalence of disability in patients with musculoskeletal pain and rheumatic diseases in a population from Cuenca, Ecuador. J Clin Rheumatol. 2017;23:324–329.
Hoy DG, Raikoti T, Smith E, et al. Use of the Global Alliance for Musculoskeletal Health Survey module for estimating the population prevalence of musculoskeletal pain: findings from the Solomon Islands. BMC Musculoskelet Disord. 2018;19:292.
Vilen L, Baldassari A, Callahan L. Socioeconomicc burden of pain in rheumatic diseases. Clin Exp Rheumatol. 2017;35:26–31.